World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
48
Citations
12342
World Ranking
4039
National Ranking
92

Laura Papi publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Laura Papi sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 109 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Laura Papi D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Laura Papi sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 48 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Laura Papi is affiliated with the University of Florence in Italy and focuses on research within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work primarily covers subfields such as Molecular Biology, Neurology, Genetics, Pulmonary and Respiratory Medicine, and Pathology and Forensic Medicine.

Their research frequently appears in publication venues including:

  • Genetics in Medicine
  • Journal of Clinical Oncology
  • Acta Neuropathologica
  • Cancers
  • JAMA Oncology

Key topics addressed in their studies include:

  • Neurofibromatosis and Schwannoma Cases
  • BRCA gene mutations in cancer
  • Sarcoma Diagnosis and Treatment
  • Chromatin Remodeling and Cancer
  • Genetic factors in colorectal cancer
  • Meningioma and schwannoma management
  • RNA modifications and cancer

Significant recent papers authored include:

  • "Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation," 2021, Genetics in Medicine
  • "Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation," 2022, Genetics in Medicine
  • "Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants," 2020, JAMA Oncology
  • "A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases," 2023, Journal of the American Society of Nephrology
  • "Epigenomic, genomic, and transcriptomic landscape of schwannomatosis," 2020, Acta Neuropathologica

Frequent co-authors collaborating with Laura Papi include:

  • Francesca Gensini
  • Eva Trevisson
  • Jaishri O. Blakeley
  • Anat Stemmer-Rachamimov
  • Gelareh Zadeh

Best Publications

  • Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A

    L M Mulligan;J B Kwok;C S Healey;M J Elsdon

  • Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

    Carl A. Anderson;Gabrielle Boucher;Charlie W. Lees;Andre Franke

  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.

    E Legius;L Messiaen;P Wolkenstein;P Pancza

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

    Roger L Milne;Roger L Milne;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Kyriaki Michailidou;Kyriaki Michailidou;Jonathan Beesley

  • Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

    Haoyu Zhang;Haoyu Zhang;Thomas U. Ahearn;Julie Lecarpentier;Daniel Barnes

  • Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

    Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee

  • Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers

    Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Lesley McGuffog;Daniel Barrowdale;Andrew Lee

  • Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

    Timothy R. Rebbeck;Tara M. Friebel;Eitan Friedman;Ute Hamann

  • High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH

    Carl E.G. Bruder;Carina Hirvelä;Isabel Tapia-Paez;Ingegerd Fransson

  • Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

    Scott Randall Plotkin;Jaishri O. Blakeley;D. Gareth Evans;C. Oliver Hanemann

  • The neurofibromatosis type 2 gene is inactivated in schwannomas

    Elapeth C. Twist;Martin H.Ruttledge;Martin H.Ruttledge;Marylene Rousseau;Marc Sanson;Marc Sanson

  • Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

    Alison M. Dunning;Kyriaki Michailidou;Karoline B. Kuchenbaecker;Deborah Thompson

  • Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

    Valentina Silvestri;Daniel Barrowdale;Anna Marie Mulligan;Anna Marie Mulligan;Susan L. Neuhausen

  • Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants : An ENIGMA resource to support clinical variant classification

    Michael T. Parsons;Emma Tudini;Hongyan Li;Eric Hahnen

  • Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2

    Emily Gardner;Laura Papi;Laura Papi;Douglas F. Easton;Tim Cummings

  • The location of constitutional neurofibromatosis 2 ( NF2 ) splice site mutations is associated with the severity of NF2

    M E Baser;L Kuramoto;R Woods;H Joe

  • DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers

    Ana Osorio;Roger L. Milne;Karoline Kuchenbaecker;Tereza Vaclová

  • Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

    Amanda B. Spurdle;Fergus J. Couch;Michael T. Parsons;Lesley McGuffog

  • Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

    Antonis C Antoniou;Karoline B Kuchenbaecker;Penny Soucy;Jonathan Beesley

Frequent Co-Authors

Irene L. Andrulis
Irene L. Andrulis University of Toronto
Paolo Radice
Paolo Radice Fondazione IRCCS Istituto Nazionale dei Tumori
Melissa C. Southey
Melissa C. Southey Monash University
Paolo Peterlongo
Paolo Peterlongo Memorial Sloan Kettering Cancer Center
Marco Montagna
Marco Montagna Istituto Oncologico Veneto
Esther M. John
Esther M. John Stanford University
Heli Nevanlinna
Heli Nevanlinna University of Helsinki
Anna Jakubowska
Anna Jakubowska Pomeranian Medical University
Fergus J. Couch
Fergus J. Couch Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Genetics in the USA opens doors to diverse career options in healthcare, research, and academia. Many students interested in Genetics also explore related fields like nursing, healthcare administration, and allied health professions.

For those looking to transition into nursing, there are nursing programs that don't require teas, making the application process more accessible. Fast-track options are also available, such as a lpn accelerated program, which can help you qualify for nursing roles quickly.

Leadership and administrative career pathways are growing in demand. Pursuing online mha programs affordable can help genetics graduates enter healthcare management and policy roles. For those aiming at advanced research or university teaching careers, phd in nursing online programs offer flexibility and the ability to expand your expertise remotely.

With an array of online and accelerated options, the path from a Genetics background to a rewarding healthcare career has never been more flexible or accessible.

Best Scientists Citing Laura Papi

Trending Scientists

Recently Published Articles